未登录

B

Binghe Xu

Peking Union Medical College

H指数:6

被引数:2,287

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis

曲妥珠单抗和帕妥珠单抗联合卡铂为基础的新辅助治疗用于HER2阳性乳腺癌：一项前瞻性队列研究，包含整合基因组学和转录组学生物标志物分析

Therapeutic Advances in Medical Oncology

IF4.2

2025-12-210

PRE

Multicellular force coordination constructs microchannel networks for barrier-free metastasis across extracellular matrix

多细胞力协调构建跨细胞外基质无障碍转移的微通道网络

SCIENCE ADVANCES

IF12.5

2025-12-190

PRE

The characteristics of HER2-positive microinvasive breast cancer and the necessity of systemic adjuvant therapy in these patients: a multicenter real-world study

HER2阳性微浸润性乳腺癌的特点及这些患者系统性辅助治疗的必要性：一项多中心真实世界研究

Therapeutic Advances in Medical Oncology

IF4.2

2025-06-160

OA

Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2-mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trials

沙西妥昔单抗戈维他宁与医生选择治疗方案在先前治疗过的HR+和HER2-mBC中的疗效：TROPiCS-02和EVER-132-002试验的荟萃分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2025-03-140

OA

Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study

依维莫司治疗激素受体阳性和人表皮生长因子受体2阴性晚期乳腺癌患者及其疗效预测模型: 一项多中心真实世界研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-11-160

OAAI

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Dalpiciclib与来曲唑/阿那曲唑或氟维司群联合治疗HR阳性和HER2-negative晚期乳腺癌: Ib期研究的结果

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-09-020

OAAI

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

6th和7th晚期乳腺癌管理国际共识指南 (ABC指南6和7)

IF7.9

2024-08-0122

OAAI

Cardoso, Fatima; Paluch-Shimon, Shani; Schumacher-Wulf, Eva; Matos, Leonor; Gelmon, Karen; Aapro, Matti S.; Bajpai, Jyoti; Barrios, Carlos H.; Bergh, Jonas; Bergsten-Nordstrom, Elizabeth; Biganzoli, Laura; Cardoso, Maria Joao; Carey, Lisa A.; Chavez-MacGregor, Mariana; Chidebe, Runcie; Cortes, Javier; Curigliano, Giuseppe; Dent, Rebecca A.; El Saghir, Nagi S.; Eniu, Alexandru; Fallowfield, Lesley; Francis, Prudence A.; Millan, Sandra X. Franco; Gilchrist, Jenny; Gligorov, Joseph; Gradishar, William J.; Haidinger, Renate; Harbeck, Nadia; Hu, Xichun; Kaur, Ranjit; Kiely, Belinda; Kim, Sung-Bae; Koppikar, Smruti; Kuper-Hommel, Marion J. J.; Lecouvet, Frederic E.; Mason, Ginny; Mertz, Shirley A.; Mueller, Volkmar; Myerson, Claire; Neciosup, Silvia; Offersen, Birgitte, V; Ohno, Shinji; Pagani, Olivia; Partridge, Ann H.; Penault-Llorca, Frederique; Prat, Aleix; Rugo, Hope S.; Senkus, Elzbieta; Sledge, George W.; Swain, Sandra M.; Thomssen, Christoph; Vorobiof, Daniel A.; Vuylsteke, Peter; Wiseman, Theresa; Xu, Binghe; Costa, Alberto; Norton, Larry; Winer, Eric P.